Indeed, HDACi-mediated reduction of VEGF expression by 4-phenylbutyrate, or decrease of tumour vasculature by MS-27-275 have been previously described in NB tumour xenograft model [16,20]. The gene discussed is VEGFA; the disease is neuroblastoma.